Article Details

Trial enrollment for uUTI drug stopped early after primary outcome for efficacy was reached

Retrieved on: 2022-11-05 13:16:44

Tags for this article:

Click the tags to see associated articles and topics

Trial enrollment for uUTI drug stopped early after primary outcome for efficacy was reached. View article details on hiswai:

Excerpt

Responses to gepotidacin were analyzed in comparison to nitrofurantoin in the phase 3 EAGLE-2 and 3 trials, which included patient data from over 3000 ...

Article found on: www.urologytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up